2019
DOI: 10.1016/j.joms.2019.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Valeriana officinalis l. (Valerian) for Conscious Sedation of Patients During the Extraction of Impacted Mandibular Third Molars: A Randomized, Split-Mouth, Double-Blind, Crossover Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0
14

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(31 citation statements)
references
References 26 publications
0
17
0
14
Order By: Relevance
“…Both quantitative and qualitative studies with human subjects were included. Of 40 articles using valerian as a single herb, 36 studies were randomized controlled trials (RCT) 3065 and 2 studies were observational. 66,67 Two studies addressed the potential induction of liver enzyme cytochrome P450 (CYP) isoforms.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Both quantitative and qualitative studies with human subjects were included. Of 40 articles using valerian as a single herb, 36 studies were randomized controlled trials (RCT) 3065 and 2 studies were observational. 66,67 Two studies addressed the potential induction of liver enzyme cytochrome P450 (CYP) isoforms.…”
Section: Resultsmentioning
confidence: 99%
“…Seven studies examined valerian’s anxiolytic potential, and positive outcomes were observed in 6 studies. 33,35,43,60,63,71 Valerian standardized extract 600 mg per day for 1 week reduced psychological and physiological stress reactivity under stress in healthy adult subjects 43 (RCT [Jadad scale 1]). Average 81.3 mg per day of valepotriates for 4 weeks reduced the score of HAM-A in generalized anxiety disorder patients 71 (RCT [Jadad scale 5]), suggesting that valepotriates are the active anxiolytic constituents.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Anxiety disorders are common prevalent mental disorders (0.9%-28.3%) (Baxter et al, 2013). Farah et al (2019) investigated the anti-anxiety effect of V. officinalis (100 mg in capsules, 60 minutes before the surgical procedure) and compared its effectiveness with midazolam (15 mg in tablets) in patients with anxiety due to bilateral extraction of mandibular third molars. This study revealed that midazolam is more potent as an anxiolytic drug, but V. officinalis causes less adverse effects (sedation and somnolence).…”
Section: Clinical Trialsmentioning
confidence: 99%
“…Moreover, valerian (2 capsules daily for three months) reduced emotional, physical, and behavioral symptoms of premenstrual syndrome in women university students (Behboodi Moghadam et al, 2016). Regarding adverse effects, only two of the thirteen clinical trials have reported adverse drug reactions (Ahmadi et al, 2017;Farah et al (2019). Remarkably, these adverse events were dizziness, somnolence, and nausea.…”
Section: Clinical Trialsmentioning
confidence: 99%